Literature DB >> 17522203

Studying hepatitis C virus: making the best of a bad virus.

Timothy L Tellinghuisen1, Matthew J Evans, Thomas von Hahn, Shihyun You, Charles M Rice.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17522203      PMCID： PMC1951464          DOI： 10.1128/JVI.00753-07

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


× No keyword cloud information.
  253 in total

1.  Crystal structure of RNA helicase from genotype 1b hepatitis C virus. A feasible mechanism of unwinding duplex RNA.

Authors:  H S Cho; N C Ha; L W Kang; K M Chung; S H Back; S K Jang; B H Oh
Journal:  J Biol Chem       Date:  1998-06-12       Impact factor: 5.157

2.  Functional role of hepatitis C virus chimeric glycoproteins in the infectivity of pseudotyped virus.

Authors:  L M Lagging; K Meyer; R J Owens; R Ray
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

3.  Complex of NS3 protease and NS4A peptide of BK strain hepatitis C virus: a 2.2 A resolution structure in a hexagonal crystal form.

Authors:  Y Yan; Y Li; S Munshi; V Sardana; J L Cole; M Sardana; C Steinkuehler; L Tomei; R De Francesco; L C Kuo; Z Chen
Journal:  Protein Sci       Date:  1998-04       Impact factor: 6.725

4.  Structures of two RNA domains essential for hepatitis C virus internal ribosome entry site function.

Authors:  P J Lukavsky; G A Otto; A M Lancaster; P Sarnow; J D Puglisi
Journal:  Nat Struct Biol       Date:  2000-12

5.  In vivo analysis of the 3' untranslated region of the hepatitis C virus after in vitro mutagenesis of an infectious cDNA clone.

Authors:  M Yanagi; M St Claire; S U Emerson; R H Purcell; J Bukh
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

6.  Low density lipoprotein receptor as a candidate receptor for hepatitis C virus.

Authors:  M Monazahian; I Böhme; S Bonk; A Koch; C Scholz; S Grethe; R Thomssen
Journal:  J Med Virol       Date:  1999-03       Impact factor: 2.327

7.  An internal polypyrimidine-tract-binding protein-binding site in the hepatitis C virus RNA attenuates translation, which is relieved by the 3'-untranslated sequence.

Authors:  T Ito; M M Lai
Journal:  Virology       Date:  1999-02-15       Impact factor: 3.616

8.  Binding of hepatitis C virus to CD81.

Authors:  P Pileri; Y Uematsu; S Campagnoli; G Galli; F Falugi; R Petracca; A J Weiner; M Houghton; D Rosa; G Grandi; S Abrignani
Journal:  Science       Date:  1998-10-30       Impact factor: 47.728

9.  The 3'-untranslated region of hepatitis C virus RNA enhances translation from an internal ribosomal entry site.

Authors:  T Ito; S M Tahara; M M Lai
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

10.  Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line.

Authors:  V Lohmann; F Körner; J Koch; U Herian; L Theilmann; R Bartenschlager
Journal:  Science       Date:  1999-07-02       Impact factor: 47.728
View more
  61 in total

Review 1.  Mixing the right hepatitis C inhibitor cocktail.

Authors:  Michael A Gelman; Jeffrey S Glenn
Journal:  Trends Mol Med       Date:  2010-11-23       Impact factor: 11.951

2.  Exiting from uncharted territory: hepatitis C virus assembles in mouse cell lines.

Authors:  Margaret A Scull; Alexander Ploss
Journal:  Hepatology       Date:  2012-02       Impact factor: 17.425

3.  Protein kinase D negatively regulates hepatitis C virus secretion through phosphorylation of oxysterol-binding protein and ceramide transfer protein.

Authors:  Yutaka Amako; Gulam H Syed; Aleem Siddiqui
Journal:  J Biol Chem       Date:  2011-02-01       Impact factor: 5.157

4.  Systematic identification of anti-interferon function on hepatitis C virus genome reveals p7 as an immune evasion protein.

Authors:  Hangfei Qi; Virginia Chu; Nicholas C Wu; Zugen Chen; Shawna Truong; Gurpreet Brar; Sheng-Yao Su; Yushen Du; Vaithilingaraja Arumugaswami; C Anders Olson; Shu-Hua Chen; Chung-Yen Lin; Ting-Ting Wu; Ren Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-03       Impact factor: 11.205

Review 5.  Direct-acting antiviral agents for hepatitis C virus infection.

Authors:  Jennifer J Kiser; Charles Flexner
Journal:  Annu Rev Pharmacol Toxicol       Date:  2012-11-05       Impact factor: 13.820

Review 6.  Revisiting Hepatitis B Virus: Challenges of Curative Therapies.

Authors:  Jianming Hu; Ulrike Protzer; Aleem Siddiqui
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

7.  Impaired toll-like receptor 3-mediated immune responses from macrophages of patients chronically infected with hepatitis C virus.

Authors:  Feng Qian; Christopher R Bolen; Chunxia Jing; Xiaomei Wang; Wei Zheng; Hongyu Zhao; Erol Fikrig; R Douglas Bruce; Steven H Kleinstein; Ruth R Montgomery
Journal:  Clin Vaccine Immunol       Date:  2012-12-05

8.  Pan-genotypic Hepatitis C Virus Inhibition by Natural Products Derived from the Wild Egyptian Artichoke.

Authors:  Mahmoud Fahmi Elsebai; George Koutsoudakis; Verónica Saludes; Gemma Pérez-Vilaró; Ari Turpeinen; Sampo Mattila; Anna Maria Pirttilä; Fabien Fontaine-Vive; Mohamed Mehiri; Andreas Meyerhans; Juana Diez
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

9.  Translation and replication of hepatitis C virus genomic RNA depends on ancient cellular proteins that control mRNA fates.

Authors:  Nicoletta Scheller; Leonardo Bruno Mina; Rui Pedro Galão; Ashwin Chari; Mireia Giménez-Barcons; Amine Noueiry; Utz Fischer; Andreas Meyerhans; Juana Díez
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-23       Impact factor: 11.205

Review 10.  Towards a small animal model for hepatitis C.

Authors:  Alexander Ploss; Charles M Rice
Journal:  EMBO Rep       Date:  2009-10-16       Impact factor: 8.807
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.